Literature DB >> 22037708

A new flow control technique using diluted epinephrine in the N-butyl-2-cyanoacrylate embolization of visceral artery pseudoaneurysms secondary to chronic pancreatitis.

Hiroyuki Morishita1, Takuji Yamagami, Yoshito Takeuchi, Tomohiro Matsumoto, Shunsuke Asai, Koji Masui, Hideki Sato, Fumihiro Taniguchi, Osamu Sato, Tsunehiko Nishimura.   

Abstract

Although n-butyl-2-cyanoacrylate (NBCA) has been used as an effective liquid embolization material, its indication for pseudoaneurysms has seemingly been limited because of the technical difficulties of using NBCA, such as reflux to the parent artery and causing significant infarction. Thus, considerable skill in using NBCA or a device to control blood flow during its polymerization is required to achieve embolization without severe complications. We report our new technique for controlling blood flow using diluted epinephrine in transcatheter arterial NBCA embolization of five pseudoaneurysms in four cases secondary to hemosuccus pancreaticus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037708     DOI: 10.1007/s00270-011-0294-8

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  2 in total

1.  Endovascular management of visceral artery aneurysms: When to watch, when to intervene?

Authors:  Romaric Loffroy; Sylvain Favelier; Pierre Pottecher; Pierre-Yves Genson; Louis Estivalet; Sophie Gehin; Jean-Pierre Cercueil; Denis Krausé
Journal:  World J Radiol       Date:  2015-07-28

2.  Guidelines for the use of NBCA in vascular embolization devised by the Committee of Practice Guidelines of the Japanese Society of Interventional Radiology (CGJSIR), 2012 edition.

Authors:  Yoshito Takeuchi; Hiroyuki Morishita; Yozo Sato; Shingo Hamaguchi; Noriaki Sakamoto; Hiroyuki Tokue; Takafumi Yonemitsu; Kenji Murakami; Hiroyasu Fujiwara; Keitaro Sofue; Toshi Abe; Hideyuki Higashihara; Yasuo Nakajima; Morio Sato
Journal:  Jpn J Radiol       Date:  2014-06-03       Impact factor: 2.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.